Venous Blood: Collect 4mL, store at 2-8°C. Transport with biological ice packs (2-8°C) within 72 hours. Use an EDTA anticoagulant tube.
Reporting Cycle
10 working days
Clinical Application Overview
1. Chromosomal Abnormalities Screening: Screen for chromosomal abnormalities in children with developmental issues, intellectual disabilities, multiple malformations, and other illnesses. Provide guidance for disease confirmation and treatment.
2. Genetic Causes Identification: Identify genetic causes of recurrent miscarriage and infertility. Offer follow-up fertility guidance and recommendations.
What is IVF Preimplantation Genetic Testing (PGT)?June 20, 20221. What is Preimplantation Genetic Testing (PGT)?Preimplantation genetic testing (PGT) is a method of screening some cells from an embryo and detecting related genetic and chromosomal disorders. This ...view
Microarray Platforms in Genetic Research: Mapping the Human GenomeJuly 18, 2024In recent years, the advancements in genetic research have revolutionized our understanding of the human genome. At the forefront of these developments is the Microarray Platform, a pivotal technology...view
Chromosome Microarray (CMA) Detection 2.0 (4)August 27, 2024Testing ContentDetection of 23 pairs of chromosomal aneuploidy and whole genome chromosomal abnormalities greater than 100kb.Testing MethodMicroarray Chip methodCMA ChipSample RequirementsMiscarriage ...view
Introduction and Application of Microarray ChipJune 20, 20221. Definition of Microarray ChipMicroarray chip refers to the use of light-guided in-situ synthesis or micro-spotting methods to solidify a large number of biological macromolecules such as nucleic ac...view